Apple Inc. vs. YUBO INTL BIOTECH LTD A
Apple Inc. and YUBO INTL BIOTECH LTD A are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| AAPL | YBGJ | |
|---|---|---|
| Market Cap | $4.77 trillion | — |
| Revenue (TTM) | $466.82 billion | — |
| Net Income (TTM) | $128.93 billion | — |
AAPL and YBGJ split the size & scale factors evenly.
Valuation
| AAPL | YBGJ | |
|---|---|---|
| P/E Ratio | 37.49 | — |
| Price / Book | 44.33 | — |
| Price / Sales | 10.21 | — |
AAPL and YBGJ split the valuation factors evenly.
Profitability
| AAPL | YBGJ | |
|---|---|---|
| Net Margin | 27.62% | — |
| Return on Equity | 119.91% | — |
AAPL and YBGJ split the profitability factors evenly.
Dividend
| AAPL | YBGJ | |
|---|---|---|
| Dividend Yield | 0.33% | — |
| Payout Ratio | 12.40 | — |
AAPL and YBGJ split the dividend factors evenly.
Risk & Sentiment
| AAPL | YBGJ | |
|---|---|---|
| Short Interest | 0.31% | — |
AAPL and YBGJ split the risk & sentiment factors evenly.
Dig deeper: AAPL overview, AAPL financials, YBGJ overview, YBGJ financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.